India's Biocon Ltd reported a 47 percent rise in June-quarter profit on Thursday, helped by higher income from its biologics and research services businesses.
Recommended Articles
View All
Ways to save tax other than Section 80C with your home loan
Feb 7, 2023 IST3 Min(s) Read
From boyhood heartthrob to a serious musician
Feb 7, 2023 IST6 Min(s) Read
Make In India | 2023 to bring fresh opportunities for textile industry and trade
Feb 7, 2023 IST3 Min(s) Read
Delhi fails to get a mayor for third time — What's the issue and what happens next
Feb 6, 2023 IST4 Min(s) Read
Net profit rose to 1.20 billion rupees ($17.48 million) for the quarter ended June 30, from 813 million rupees last year, India's largest biotechnology company's said in a statement.
Revenue from operations rose 20.4 percent to 11.24 billion rupees.
Analysts on average were expecting a net profit of 1.12 billion rupees, according to Thomson Reuters